Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Project HALT II: Health Literacy and Smoking Cessation
NCT02942212Phase 1Withdrawn
- Sponsor
- University of Texas MD Anderson Cancer Center
- Start
- Dec 2018
- Primary completion
- Dec 2018
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial (3 arms), sponsored by University of Texas MD Anderson Cancer Center. Primary endpoint: Efficacy of Helping Adults with Health Literacy Trouble (HALT) versus Standard Treatment (ST) in Facilitating Abstinence from Smoking at 3 months. Planned start Dec 2018; status: withdrawn.
Beyond the preview
Go deeper on NCT02942212.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02942212.